Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL2120495 | 0.84 | LMNA (0.48) | — | |
| Acrylic Acid SCHEMBL34299 | 0.84 | LMNA (0.48) | — | |
| Urea SCHEMBL28462120 | 0.83 | TSHR (0.37) | TSHRALDH1A1 | |
| Carbamic Acid SCHEMBL699756 | 0.80 | ACHE (0.39) | TSHRALDH1A1 | |
| Ethylene SCHEMBL28733226 | 0.77 | KDM4E (0.32) | — | |
| Hydroxyamine SCHEMBL1245058 | 0.77 | KDM4E (0.32) | TSHR | |
| SCHEMBL338264 | 0.77 | KDM4E (0.34) | ALDH1A1 | |
| SCHEMBL785147 | 0.77 | — | — | |
| SCHEMBL1123 | 0.77 | — | — | |
| Acrylic Acid SCHEMBL28255564 | 0.77 | LMNA (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3561513-A1 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | Ventana Medical Systems, Inc. (US) | 2019-10-30 | — | — | EP | claimed |
| US-9575067-B2 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. (US) | 2017-02-21 | — | — | US | claimed |
| US-20150309039-A1 | Polymeric Carriers for Immunohistochemistry and In Situ Hybridization | VENTANA MEDICAL SYSTEMS | 2015-10-29 | — | — | US | claimed |
| US-9103822-B2 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. (US) | 2015-08-11 | — | — | US | claimed |
| US-9017954-B2 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20140243236-A1 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2014-08-28 | — | — | US | claimed |
| US-20130273565-A1 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2013-10-17 | — | — | US | claimed |
| US-8486620-B2 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. (US) | 2013-07-16 | — | — | US | claimed |
| US-8445191-B2 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. (US) | 2013-05-21 | — | — | US | claimed |
| US-20110245098-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. | 2011-10-06 | — | — | US | claimed |
| US-20110244544-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. | 2011-10-06 | — | — | US | claimed |
| US-20110244545-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. | 2011-10-06 | — | — | US | claimed |
| EP-2167963-A2 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | Ventana Medical Systems, Inc. (US) | 2010-03-31 | — | — | EP | claimed |
| WO-2008153744-A2 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2008-12-18 | — | — | WO | claimed |
| US-20080305497-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. | 2008-12-11 | — | — | US | claimed |
| CN-117695438-A | Reinforced hydrogel material for promoting tissue repair, hydrogel film patch and preparation method | 北京科技大学 | 2024-03-15 | — | — | CN | disclosed |
| EP-3561513-A1 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | Ventana Medical Systems, Inc. (US) | 2019-10-30 | — | — | EP | disclosed |
| EP-2167963-A2 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | Ventana Medical Systems, Inc. (US) | 2010-03-31 | — | — | EP | disclosed |
| WO-2008153744-A2 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| US-20080305497-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110244545-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | FCGR2A, CD68, CA14 | TSHR 2068/4885ALDH1A1 180/4885FGFR4 457/4885 |
| US-20150309039-A1 | Polymeric Carriers for Immunohistochemistry and In Situ Hybridization | FCGR2A, CD68, CA14 | TSHR 2068/4885ALDH1A1 180/4885FGFR4 457/4885 |
| US-20140243236-A1 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | FCGR2A, CD68, CA14 | TSHR 2068/4885ALDH1A1 180/4885FGFR4 457/4885 |
| US-20080305497-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | FCGR2A, CD68, CA14 | TSHR 2068/4885ALDH1A1 180/4885FGFR4 457/4885 |
| US-20110244544-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | FCGR2A, CD68, CA14 | TSHR 2068/4885ALDH1A1 180/4885FGFR4 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.